108 filings
Page 4 of 6
8-K
abtvqezlns 1jo
8 May 19
Proteon Therapeutics Announces First Quarter 2019 Financial Results
8:01am
8-K
4f6 0w05hpb
15 Apr 19
Proteon Therapeutics Announces Review of Potential Strategic Transactions
4:30pm
8-K
b7zu7
28 Mar 19
Proteon Therapeutics Announces Top-Line Results From Phase 3 PATENCY-2 Clinical Trial of Vonapanitase in Radiocephalic Arteriovenous Fistulas
8:00am
8-K
6iodm
13 Mar 19
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2018 Financial Results
8:00am
8-K
brk07r
7 Nov 18
Proteon Therapeutics Announces Third Quarter 2018 Financial Results
8:01am
8-K
q0ey4tjbq61csb
7 Aug 18
Proteon Therapeutics Announces Second Quarter 2018 Financial Results
8:01am
8-K
cern8qc366jpn5gv6
11 Jun 18
Submission of Matters to a Vote of Security Holders
4:30pm
8-K
26oeabsy
9 May 18
Proteon Therapeutics Announces First Quarter 2018 Financial Results
8:10am
8-K
q8a j6joyhcz0ok
8 May 18
Proteon Therapeutics and Lonza Extend Manufacturing Agreement for Commercial Supply
7:10am
8-K
2pbbfnjm0n4v2ycy
14 Mar 18
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial Results
12:00am
8-K
nbuy5qdmq0p900
14 Mar 18
Other Events
12:00am
8-K
xh3 62mq3z00a6b5dp5
5 Mar 18
Proteon Therapeutics Completes Enrollment in PATENCY-2, Phase 3 Clinical Trial of Investigational Vonapanitase
12:00am
8-K
yrc3imqke3a83dku2ibb
7 Nov 17
Proteon Therapeutics Announces Third Quarter 2017 Financial Results
12:00am
8-K
bhxzmn8s2yno 9us1
22 Aug 17
Entry into a Material Definitive Agreement
12:00am
8-K
1gcq0nqh rcmjf89
7 Aug 17
Proteon Therapeutics Announces Second Quarter 2017 Financial Results
12:00am
8-K
vybjl
3 Aug 17
Proteon Therapeutics Announces Closing of $22 Million Convertible Preferred Stock Financing
12:00am
8-K
kxrc9sa
26 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
vaa46f kn1k2qv
23 Jun 17
Entry into a Material Definitive Agreement
12:00am
8-K
9jf3snrh
22 Jun 17
Proteon Therapeutics Announces $22.0 Million Private Placement
12:00am
8-K
9gaqwwzqp
10 May 17
Proteon Therapeutics Announces First Quarter 2017 Financial Results
12:00am